【基因改造的大肠杆菌,帮你吸光身体里排不掉的废物】

【基因改造的大肠杆菌,帮你吸光身体里排不掉的废物】对一般人来说,尿素循环会将身体里含氮的代谢废物,主要是毒性较强的氨,转化成尿素后经肾脏随尿液排出,尿素循环障碍的患者会导致氨累积,有些病患症状严重还需要肝脏移植。美国生技公司 Synlogic 研发出一种基因改造的大肠杆菌,能帮尿素循环障碍疾病(Urea Cycle Disorders)的患者“吸走”身体无法排除的毒素。Synlogic CEO Gutierrez-Ramos 表示,今年 12 月就能知道这个产品对人体是否安全,如果状况良好,希望明年开始运用在病患身上。http://www.looooker.com/?p=50136

Gulp. These Volunteers Are Swallowing E. Coli Pills to Help Medicine

Biologists are genetically modifying the DNA of stomach bacteria so they act like living drugs.

1

Somewhere in Baltimore, volunteers are gulping capsules filled with GMOs—gene-modified E. coli bacteria, to be precise.

Synlogic of Cambridge, Massachusetts, the company behind the unusual study, is testing what it calls “synthetic biotics,” or bacteria engineered to carry out specialized jobs in a person’s stomach.

Inside the pills are E. coli engineered to sop up ammonia inside the gut of people who can’t get rid of it fast enough. The study signals how genetic engineers are hoping to harness the microbiome, as the trillions of microscopic organisms that dwell within you are known.

The drug is designed to help people suffering from disorders of the “urea cycle.” That’s the metabolic flywheel inside your liver that gets rid of excess nitrogen. For people whose urea cycles are faulty, excess nitrogen turns into ammonia, just like what’s under your kitchen sink, and just as hazardous.

Though the condition is rare, for some people it’s serious enough to require a liver transplant.

This study, which began in June, doesn’t yet involve any sick patients. Instead, it’s a safety trial. The volunteers taking the drug collect a fee for swallowing GM germs to advance knowledge. They have to live in a testing facility for as long as three weeks so technicians can monitor them and collect their poop for DNA analysis.

Of the 50 people the trial is meant to study, Synlogic CEO J.C. Gutierrez-Ramos says “many” have already taken the new GMO pill. Others, picked at random, have gotten a placebo. The trial is being carried out at one hospital in Maryland.

The drug represents a concrete application of synthetic biology, which is the idea of engineering an organism’s metabolism to produce fuel, drugs, perfumes, or other chemicals. Previously, a company called ActoGenix undertook studies in Europe of a GM version of the bacterium Lactococcus lactis that it had altered so it released a protein drug. In the U.S., Marina Biotech also carried out a small safety test of anti-cancer bacteria, also genetically modified.

The U.S. Food and Drug Administration, which considers such drugs to be “live biological products,” this summer fast-tracked Synlogic’s application to try it on people. Gutierrez-Ramos says Synlogic will know if it’s safe by December and hopes to start up studies in actual patients next year.

原文链接:

https://www.technologyreview.com/s/608950/gulp-these-volunteers-are-swallowing-e-coli-pills-to-help-medicine/


Comments are closed.



无觅相关文章插件